Lenvima, Keytruda combo shows anti-tumour activity

30th September 2019 Uncategorised 0

Following the positive results of the trial, the companies have announced that the LEAP-001 Phase III study is now underway.

More: Lenvima, Keytruda combo shows anti-tumour activity
Source: News